Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.
Oemar
B
B
Brodehl
J
J
D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D013997:Time Factors
D003520:Cyclophosphamide; D011241:Prednisone